Urinary leukotriene E4 excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants

Shahid Sheikh, Donald Null, Deborah Gentile, Colleen Bimle, David Skoner, Karen McCoy, Robert Guthrie

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Background: Inflammation plays an important role in the pathogenesis of bronchopulmonary dysplasia (BPD), but the exact nature of this inflammatory process is incompletely understood. Older infants with established BPD have higher levels of urinary leukotriene E4 (LTE4) compared to healthy infants of the same age. This suggests that cysteinyl leukotrienes may play a role in the abnormalities seen in BPD. Objectives: To measure urinary LTE4 levels during the first month of life in premature infants, and to determine whether there are significant differences in premature infants who develop BPD, as compared to those who do not develop BPD. Design: Prospective, blinded, controlled study. Setting: Neonatal ICUs of a tertiary-care university hospital. Methods: Thirty-seven premature infants (<33 weeks of gestational age) were enrolled prospectively at birth. Urinary LTE4 levels were measured blinded, using a standard radioimmunoassay technique at 2 days, 7 days, and 28 days of life. At 1 month of age, infants were classified as with or without BPD, based on need for supplemental oxygen, and characteristic chest radiographs. Clinical features and urinary LTE4 were compared between the two groups. Results: Mean ± SD gestational age was 29 ± 2.6 weeks. None of the infants had a family history of asthma. Thirteen of 37 infants were classified as having BPD at 28 days after birth. Mean gestational age in infants who developed BPD was 27 ± 2.4 weeks, compared to 30 ± 2 weeks in infants who did not develop BPD (p < 0.05). In infants with BPD, mean urinary LTE4 levels of urinary creatinine were 1,762 ± 2,003 pg/mg, 1,236 ± 992 pg/mg, and 5,541 ± 5,146 pg/mg at days 2, 7, and 28, respectively, compared to 1,304 ± 1,195 pg/mg, 1,158 ± 1,133 pg/mg, and 2,800 ± 2,080 pg/mg in infants without BPD. LTE4 levels at 2 days, 7 days, and 28 days did not correlate with the subsequent development of BPD. LTE4 levels at day 28 were significantly higher than LTE4 levels at day 2 and day 7 in both groups, even after correcting for gestational age or birth weight (p < 0.05). There was significant inverse correlation between LTE4 levels at day 2 with gestational age and birth weight (p < 0.05). All 13 infants with BPD received steroid pulses, compared to 3 of 26 infants without BPD. Gestational age and use of postnatal steroid pulses, diuretics, and theophylline (for apnea of prematurity) were significantly associated with each other and with the subsequent development of BPD. Conclusion: Urinary LTE4 levels measured on the second day of life in very-low-birth-weight infants inversely correlate with gestational age and birth weight. Urinary LTE4 levels may reflect lung injury and/or inflammation in premature infants, not necessarily related to BPD as it is presently defined.

Original languageEnglish (US)
Pages (from-to)1749-1754
Number of pages6
JournalChest
Volume119
Issue number6
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Keywords

  • Bronchopulmonary dysplasia
  • Infants
  • Leukotrienes
  • Prematurity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Urinary leukotriene E<sub>4</sub> excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants'. Together they form a unique fingerprint.

  • Cite this